Back to Top

Letters in Drug Design & Discovery (LDDD)

Publisher :

Bentham Science Publishers

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Drug Design
  • Biochemistry in Drug Design
  • Toxicology
  • +7

e-ISSN :

1875-628X

Issue Frequency :

Monthly

Impact Factor :

1.2

p-ISSN :

1570-1808

Est. Year :

2004

Mobile :

97165571132

DOI :

YES

Country :

United Arab Emirates

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

lddd@benthamscience.net

Journal Descriptions

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.


Letters in Drug Design & Discovery (LDDD) is :

International, Peer-Reviewed, Open Access, Refereed, Drug Design, Biochemistry in Drug Design, Toxicology, Pharmaceutics, Pharmacology, Molecular Pharmacology, Biochemistry, Genetics and Molecular Biology (General), Drug Discovery, Toxicology and Pharmaceutics (General) , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 1570-1808, E-ISSN - 1875-628X, Established in - 2004, Impact Factor - 1.2

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile